作者:Aurang Zeb、Imran Malik、Saima Rasheed、Muhammad Iqbal Choudhary、Fatima Z. Basha
DOI:10.2174/157340612802084360
日期:2012.9.1
metronidazole ester derivatives 1-34 has been synthesized with the aim of developing new leads with antiglycation activity. The in vitro evaluation of antiglycation potential of 1-34 showed that the ester derivatives 28, 16, and 3 have IC(50) values 218.97 ± 2.5, 245.3 ± 5.1, and 278.6 ± 0.8 µM, respectively, comparable to the standard agent, rutin (IC(50) = 294.5 ± 1.50 µM). The study identifies a new class
已经合成了一系列甲硝唑酯衍生物1-34,目的是开发具有抗糖基化活性的新的前导物。体外抗糖化能力为1-34的评估表明,酯衍生物28、16和3的IC(50)值分别为218.97±2.5、245.3±5.1和278.6±0.8 µM,与标准药物相当,芦丁(IC(50)= 294.5±1.50 µM)。该研究确定了一类新的有效抗糖化剂。构效关系也得到了评估。所有化合物均使用光谱技术进行了表征,包括(1)H NMR,IR和EI-MS。